More articles from 5.1 Airway Pharmacology and Treatment

A single-dose double-blind study comparing efficacy of two dry powder inhalers containing budesonide and formoterol in asthmatic patients
Satu Lahelma, Mikko Vahteristo, Hristo Metev, Margarita Taseva, Nadezhda Stamatova, Anna Bartha, Judit Schlezák, Ulla Sairanen

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4124; DOI: 10.1183/13993003.congress-2016.PA4124
Assessing COPD profiles and outcomes by dyspnoea severity
Antonio R. Anzueto, Peter M.A. Calverley, Robert A. Wise, Achim Mueller, Norbert Metzdorf, Daniel Dusser

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4057; DOI: 10.1183/13993003.congress-2016.PA4057
Secondary analysis of the UPLIFT® trial by body mass index
Donald P. Tashkin, Antonio Anzueto, Norbert Metzdorf, Achim Mueller, Ulrika Hinkel, Bartolome Celli

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4049; DOI: 10.1183/13993003.congress-2016.PA4049
Treatment of combined pulmonary fibrosis and emphysema
Jee Youn Oh, Juwhan Choi, Sangmi Chung, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4081; DOI: 10.1183/13993003.congress-2016.PA4081
Onset of action of formoterol/budesonide (F/B) Spiromax® compared with F/B Turbuhaler® in patients with COPD: A preliminary report
Josuel Ora, Alessandra Di Paolo, Gabriella Lucà, Luigino Calzetta, Paola Rogliani, Mario Cazzola

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4059; DOI: 10.1183/13993003.congress-2016.PA4059
Glaucoma risk due to antimuscarinics, not a class effect: A systematic review
Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4069; DOI: 10.1183/13993003.congress-2016.PA4069
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Peter M.A. Calverley, Emiel F.M. Wouters, Helen Finnigan, Kay Tetzlaff, Helgo Magnussen

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4067; DOI: 10.1183/13993003.congress-2016.PA4067
Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study
Olaf Schmidt, Frank Kanniess, Petra Oepen, Birgit Langer-Brauburger

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4118; DOI: 10.1183/13993003.congress-2016.PA4118
Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD)
Maurizio Moretti

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4077; DOI: 10.1183/13993003.congress-2016.PA4077
Safety and tolerability of the NE inhibitor BAY 85-8501 in patients with non-CF bronchiectasis
Henrik Watz, Frauke Pedersen, Anne Kirsten, Johannes Nagelschmitz, Tiemo-Jörg Bandel, Stephan Schwers, Klaus Rabe

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4088; DOI: 10.1183/13993003.congress-2016.PA4088

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us